Transgenomic, Inc. Announces Third Quarter 2007 Earnings Release Conference Call Webcast

OMAHA, Neb., Nov. 1 /PRNewswire-FirstCall/ -- Transgenomic Inc. announces the following Webcast:

http://www.transgenomic.com/events.asp?id=6

To access the call via telephone, call 800-895-0198 or 785-424-1053. A replay of the call will be available via telephone until 11:59pm ET on Wednesday, November 21, 2007. To access, dial 800-839-4017 or 402-220-2984.

About Transgenomic: A decade of discovery 1997 - 2007

Transgenomic is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems, related consumables and assay kits, cytogenetics automated systems, Transgenomic Clinical Reference Laboratory and Genomic Research Services. Transgenomic Clinical Reference Laboratory and Genomic Research Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please visit: http://www.transgenomic.com.

CONTACT: Investor Relations of Transgenomic Inc., +1-402-452-5400

Web site: http://www.transgenomic.com//

MORE ON THIS TOPIC